Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Sulphamethoxazole 40 mg/mL, trimethoprim 8 mg/mL Suspension, oral Novex Pharma Inc., Richmond Hill, Ontario, Canada Apo-Sulfatrim Ciprofloxacin hydrochloride 0.35% equivalent 0.3% ciprofloxacin Drops, eye, solution S A Alcon Couvreur NV., Puurs, Belgium Ciloxan Cimetidine 200 mg, 400 mg, 800 mg Tablets Generics (UK) Limited, Potters Bar, Hertfordshire, United Kingdom and Gerard Laboratories, Dublin, Eire Duomet Famciclovir 125 mg, 250 mg Tablets SmithKline Beecham Pharmaceuticals, Magpie Wood, Manor Royal, Crawley, Sussex, England Famvir Glycerol 85% w/w Enema C B FLeet & Co Inc., Lynchburg, Virginia, United States of America Fleet Babylax Glycerol 85% w/w Enema C B FLeet & Co Inc., Lynchburg, Virginia, United States of America Fleet Glycerin Laxative Rectal Applicator Morphine sulphate 30 mg, 60 mg, 90 mg, 120 mg, 150 mg, 200 mg Capsules, modified release Bard Pharmaceuticals Limited, Cambridge, England MST-Mono Azelastine hydrochloride 0.1% w/v Spray, nasal solution Asta Medica AG., Halle-Kunsebeck, Germany Rhinolast Vigabatrin 500 mg Tablet, film coated Marion Merrel Dow France SA., Bourgoin-Jallieu Cedex, France Sabril Vigabatrin 500 mg Tablet, film coated Marion Merrel Dow France SA., Bourgoin-Jallieu Cedex, France Sabril Sevoflurane 100% Inhalation, volatile liquid Abbott Laboratories (UK) Limited, Queensborough, Kent, England and Abbott SpA., Campoverde di Aprilia, Latina, Italy Sevorane Valaciclovir hydrochloride 556 mg equivalent 500 mg valaciclovir Tablet, film coated Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom and Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Valtrex Valaciclovir hydrochloride 278 mg, 556 mg equivalent 250 mg, 500 mg valaciclovir Tablet, film coated Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom and Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom Valtrex Goserelin acetate 3.6 mg Implant, subcutaneous Zeneca Pharmaceuticals, Macclesfield, Cheshire, England Zoladex Injectable Implant Dated this 5th day of June 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.